Askari et al (2012)
The following study can be used to support the use of drug treatments for people with OCD. It focuses on granisetron, a drug that reduces serotonergic activity by binding to 5-HT(3) receptors on the postsynaptic membrane.This study may also be used on Paper 1 to answer a Biological Approach short answer questions about neurotransmission, including questions focused specifically on antagonists. Background information
To access the contents of this site, you must subscribe.